+1-504-608-2390Upcoming Special Issue
Purpose: To publish the most exciting research with respect to the subjects of Chemotherapy: Open Access and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.
Special Issue Topics
Special issue entitled: "Chemotherapy Case Reports" (Released)
Special issue entitled: Special Issue on Trends in Cancer Research
Special issue entitled: Chemotherapy side effects and precaution
Special issue entitled: "Chemotherapeutic Treatment and Strategies" (Released)
-
Yalian Yu
Department of Otorhinolaryngology
First Hospital of China Medical University
Republic of China
Special issue entitled: Current status of Nutraceuticals in Chemotherapy
-
Tetsuya Konishi
Department of Functional and Analytical Food Sciences
Niigata University of Pharmacy & Applied Life Sciences
Japan
Special issue entitled: Translational Pathology
Special issue entitled: "Immunochemotherapy" (Released)
Special issue entitled: "Cancer Chemotherapy" (Released)
-
Molinda Kearns
Assistant Professor
Department of Biology
Concordia college, New York
Tel. 917-533-7277
Special issue entitled: Antimicrobial Chemotherapy
-
Afsar Al Shibib
Associate Professor
Ontario Public Health Laboratory
Toranto, Ontario
Canada
Tel. 416-241-9866
Special issue entitled: Mechanism of cancer cell therapeutic resistance
Submission Process
Submit Special Issue articles online through manuscript submission, review and editorial tracking system for quality and quick review processing at https://www.longdom.org/chemotherapy-open-access/submit-manuscript.html or send as an e-mail attachment to the editorial office at [email protected]
Note:- In case of online submission, please select "Special Issue Article" from the dropdown list.
- In case of e-mail, please specify the title of the special issue in the subject and in the cover letter of the submission.
For further information, Please contact us at:
Longdom Publishing SL Journals
: +34 911 877 608
: [email protected]